Carbapenemases as factors of Resistance to Antibacterial Drugs
Antibiotic drugs are used to treat and prevent bacterial infections around the world. The emergence and spread of bacterial resistance to carbapenems is currently a real threat that determines the need for its timely detection and suppression. Carbapenem-resistant Enterobacteriaceae, Pseudomonas a...
Enregistré dans:
Auteur principal: | A. V. Nevezhina |
---|---|
Format: | article |
Langue: | RU |
Publié: |
Scientific Сentre for Family Health and Human Reproduction Problems
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/fba17456b56f4fb698b8ecb470d259b9 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
<italic toggle="yes">Klebsiella pneumoniae</italic> Carbapenemase-2 (KPC-2), Substitutions at Ambler Position Asp179, and Resistance to Ceftazidime-Avibactam: Unique Antibiotic-Resistant Phenotypes Emerge from β-Lactamase Protein Engineering
par: Melissa D. Barnes, et autres
Publié: (2017) -
Identification of extended spectrum beta lactamases, AmpC and carbapenemase production among isolates of Escherichia coli in North Indian tertiary care centre
par: Uma Chaudhary, et autres
Publié: (2018) -
Development and Evaluation of a Novel Protein-Based Assay for Specific Detection of KPC β-Lactamases from <named-content content-type="genus-species">Klebsiella pneumoniae</named-content> Clinical Isolates
par: Shuo Lu, et autres
Publié: (2020) -
Epidemiology of Extended-Spectrum Beta-Lactamase and Carbapenemase-Producing Enterobacterales in the Greater Mekong Subregion: A Systematic-Review and Meta-Analysis of Risk Factors Associated With Extended-Spectrum Beta-Lactamase and Carbapenemase Isolation
par: Shweta R. Singh, et autres
Publié: (2021) -
Quantitative Insights Into β-Lactamase Inhibitor’s Contribution in the Treatment of Carbapenemase-Producing Organisms With β-Lactams
par: Yanfang Feng, et autres
Publié: (2021)